Actividad de la enfermedad y depresión en una cohorte colombiana con artritis reumatoide
En varios estudios se ha identificado una conexión significativa entre la artritis reumatoide (AR) y la depresión, dado el alto índice de depresión registrado entre los pacientes con AR. La evidencia creciente sugiere que la AR puede ser un factor de riesgo para el desarrollo de depresión, y los pac...
- Autores:
-
Rodríguez Velandia, Yhojan Alexis
- Tipo de recurso:
- https://purl.org/coar/resource_type/c_7a1f
- Fecha de publicación:
- 2025
- Institución:
- Universidad El Bosque
- Repositorio:
- Repositorio U. El Bosque
- Idioma:
- spa
- OAI Identifier:
- oai:repositorio.unbosque.edu.co:20.500.12495/15545
- Acceso en línea:
- https://hdl.handle.net/20.500.12495/15545
- Palabra clave:
- Artritis reumatoide
Depresión
Actividad de la enfermedad
Rheumatoid arthritis
Depression
Disease activity
WB 115
- Rights
- License
- Attribution-NonCommercial-ShareAlike 4.0 International
| id |
UNBOSQUE2_19a23f46f5ef4ad8582db46c1a6c0e81 |
|---|---|
| oai_identifier_str |
oai:repositorio.unbosque.edu.co:20.500.12495/15545 |
| network_acronym_str |
UNBOSQUE2 |
| network_name_str |
Repositorio U. El Bosque |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Actividad de la enfermedad y depresión en una cohorte colombiana con artritis reumatoide |
| dc.title.translated.none.fl_str_mv |
Disease activity and depression in a colombian cohort with rheumatoid arthritis |
| title |
Actividad de la enfermedad y depresión en una cohorte colombiana con artritis reumatoide |
| spellingShingle |
Actividad de la enfermedad y depresión en una cohorte colombiana con artritis reumatoide Artritis reumatoide Depresión Actividad de la enfermedad Rheumatoid arthritis Depression Disease activity WB 115 |
| title_short |
Actividad de la enfermedad y depresión en una cohorte colombiana con artritis reumatoide |
| title_full |
Actividad de la enfermedad y depresión en una cohorte colombiana con artritis reumatoide |
| title_fullStr |
Actividad de la enfermedad y depresión en una cohorte colombiana con artritis reumatoide |
| title_full_unstemmed |
Actividad de la enfermedad y depresión en una cohorte colombiana con artritis reumatoide |
| title_sort |
Actividad de la enfermedad y depresión en una cohorte colombiana con artritis reumatoide |
| dc.creator.fl_str_mv |
Rodríguez Velandia, Yhojan Alexis |
| dc.contributor.advisor.none.fl_str_mv |
Quintana López, Gerardo |
| dc.contributor.author.none.fl_str_mv |
Rodríguez Velandia, Yhojan Alexis |
| dc.contributor.orcid.none.fl_str_mv |
Rodríguez Yhojan [0000-0002-0956-1491] |
| dc.subject.none.fl_str_mv |
Artritis reumatoide Depresión Actividad de la enfermedad |
| topic |
Artritis reumatoide Depresión Actividad de la enfermedad Rheumatoid arthritis Depression Disease activity WB 115 |
| dc.subject.keywords.none.fl_str_mv |
Rheumatoid arthritis Depression Disease activity |
| dc.subject.nlm.none.fl_str_mv |
WB 115 |
| description |
En varios estudios se ha identificado una conexión significativa entre la artritis reumatoide (AR) y la depresión, dado el alto índice de depresión registrado entre los pacientes con AR. La evidencia creciente sugiere que la AR puede ser un factor de riesgo para el desarrollo de depresión, y los pacientes que presentan ambas condiciones tienden a tener resultados clínicos menos favorables. No obstante, en Colombia, no se dispone de estimaciones precisas sobre la prevalencia de depresión en individuos con AR, y los estudios existentes enfrentan diversas limitaciones metodológicas. Este estudio se propone investigar la magnitud del problema de la depresión en pacientes con AR mediante la estimación de su prevalencia en una cohorte colombiana. Además, analizará cómo los síntomas depresivos influyen en la actividad de la enfermedad, al tiempo que identificará los factores que afectan la relación entre ambas enfermedades a lo largo del tiempo. |
| publishDate |
2025 |
| dc.date.accessioned.none.fl_str_mv |
2025-07-29T14:20:11Z |
| dc.date.available.none.fl_str_mv |
2025-07-29T14:20:11Z |
| dc.date.issued.none.fl_str_mv |
2025-07 |
| dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_7a1f |
| dc.type.local.spa.fl_str_mv |
Tesis/Trabajo de grado - Monografía - Especialización |
| dc.type.coar.none.fl_str_mv |
https://purl.org/coar/resource_type/c_7a1f |
| dc.type.driver.none.fl_str_mv |
info:eu-repo/semantics/bachelorThesis |
| dc.type.coarversion.none.fl_str_mv |
https://purl.org/coar/version/c_ab4af688f83e57aa |
| format |
https://purl.org/coar/resource_type/c_7a1f |
| dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/20.500.12495/15545 |
| dc.identifier.instname.spa.fl_str_mv |
instname:Universidad El Bosque |
| dc.identifier.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional Universidad El Bosque |
| dc.identifier.repourl.none.fl_str_mv |
repourl:https://repositorio.unbosque.edu.co |
| url |
https://hdl.handle.net/20.500.12495/15545 |
| identifier_str_mv |
instname:Universidad El Bosque reponame:Repositorio Institucional Universidad El Bosque repourl:https://repositorio.unbosque.edu.co |
| dc.language.iso.fl_str_mv |
spa |
| language |
spa |
| dc.relation.references.none.fl_str_mv |
1. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet (London, England). Oktober 2016;388(10055):2023–38. 2. Ionescu C-E, Popescu CC, Agache M, Dinache G, Codreanu C. Depression in Rheumatoid Arthritis: Prevalence and Effects on Disease Activity. J Clin Med. April 2024;13(7). 3. ElSherbiny DA, ElSayed Saad W. Depression in rheumatoid arthritis patients: Screening for a frequent yet underestimated comorbidity. Egypt Rheumatol [Internet]. 2020;42(2):89–93. Available at: https://www.sciencedirect.com/science/article/pii/S1110116419300882 4. Strand V, Boklage SH, Kimura T, Joly F, Boyapati A, Msihid J. High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab. Arthritis Res Ther. Oktober 2020;22(1):250. 5. Maldonado G, Ríos C, Paredes C, Ferro C, Intriago MJ, Aguirre C, et al. Depression in Rheumatoid Arthritis. Rev Colomb Reumatol (English Ed [Internet]. 2017;24(2):84–91. Available at: https://www.elsevier.es/es 6. Cui L, Li S, Wang S, Wu X, Liu Y, Yu W, et al. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther. Februarie 2024;9(1):30. 7. Fernández-Ávila DG, Rincón-Riaño DN, Bernal-Macías S, Gutiérrez Dávila JM, Rosselli D. Prevalencia de la artritis reumatoide en Colombia según información del Sistema Integral de Información de la Protección Social . Vol 26, Revista Colombiana de Reumatología . scieloco ; 2019. bl 83–7. 8. Anderson JK, Zimmerman L, Caplan L, Michaud K. Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score with 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), C. Arthritis Care Res (Hoboken). November 2011;63 Suppl 1:S14-36. 9. Toro-Gutiérrez CE, Arbeláez-Cortés Á, Fernández-Aldana AR, Mejía-Romero RA, Méndez Patarroyo P, Quintana L. G, et al. Guía de práctica clínica para la detección temprana, el diagnóstico, el tratamiento y el seguimiento de los pacientes con artritis reumatoide. Asociación Colombiana de Reumatología, 2022. Rev Colomb Reumatol [Internet]. 2017;24(2):205–22. Available at: https://www.elsevier.es/es 10. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England). November 2018;392(10159):1789–858. 11. Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G, et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. Julie 2011;9:90 12. Social FES. Estudio Nacional de Salud Mental Colombia 2003. 2003. 13. Malhi GS, Mann JJ. Depression. Lancet (London, England). November 2018;392(10161):2299–312. 14. Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, et al. Major depressive disorder. Nat Rev Dis Prim. September 2016;2:16065. 15. Arlington: American Psychiatric Publishing. Diagnostic and statistical manual of mental disorders. 2013; 16. Diez-Quevedo C, Rangil T, Sanchez-Planell L, Kroenke K, Spitzer RL. Validation and utility of the patient health questionnaire in diagnosing mental disorders in 1003 general hospital Spanish inpatients. Psychosom Med. 2001;63(4):679–86. 17. Castro-Camacho L, Escobar JM, Sáenz-Moncaleano C, Delgado-Barrera L, Aparicio-Turbay S, Molano JC, et al. [Mental Health in the General Hospital: Results of the Patient Health Questionnaire (PHQ) in Four Hospital Services]. Rev Colomb Psiquiatr. Maart 2012;41(1):61–85. 18. Tejada PA, Jaramillo LE, Sánchez-Pedraza R. Revisión crítica sobre los instrumentos para la evaluación psiquiátrica en atención primaria . Vol 62, Revista de la Facultad de Medicina . scieloco ; 2014. bl 101–10. 19. Maurer DM, Raymond TJ, Davis BN. Depression: Screening and Diagnosis. Am Fam Physician. Oktober 2018;98(8):508–15. 20. Englbrecht M, Alten R, Aringer M, Baerwald CG, Burkhardt H, Eby N, et al. Validation of Standardized Questionnaires Evaluating Symptoms of Depression in Rheumatoid Arthritis Patients: Approaches to Screening for a Frequent Yet Underrated Challenge. Arthritis Care Res (Hoboken). Januarie 2017;69(1):58–66. 21. Hitchon CA, Zhang L, Peschken CA, Lix LM, Graff LA, Fisk JD, et al. Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). Augustus 2020;72(8):1130–9. 22. Smarr KL, Keefer AL. Measures of Depression and Depressive Symptoms. Arthritis Care Res (Hoboken). Oktober 2020;72 Suppl 1:608–29. 23. Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). Desember 2013;52(12):2136–48. 24. Levis B, Benedetti A, Thombs BD. Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. April 2019;365:l1476. 25. Manne SL, Zautra AJ. Coping with arthritis. Current status and critique. Arthritis Rheum. November 1992;35(11):1273–80. 26. Kato T. Frequently Used Coping Scales: A Meta-Analysis. Stress Heal J Int Soc Investig Stress. Oktober 2015;31(4):315–23. 27. Rodríguez-Franco L, Cano-García F, Picabia Y. Evaluación de las estrategias de afrontamiento del dolor crónico. Actas Esp Psiquiatr. 01 Januarie 2004;32. 28. Guarino L, Sojo V, Bethelmy L. Adaptación y Validación Preliminar de la Versión Hispana del Cuestionario de Estilos de Afrontamiento (Coping Style Questionnaire, CSQ). Psicol Conductual. 01 Januarie 2007;15:173. 29. Delgado M, Cano-Vindel A, Pérez Nieto M. Afrontamiento y artritis reumatoide: una revisión crítica. Ansiedad y Estres. 01 Oktober 2001;7:139–50. 30. Vriezekolk JE, van Lankveld WGJM, Geenen R, van den Ende CHM. Longitudinal association between coping and psychological distress in rheumatoid arthritis: a systematic review. Ann Rheum Dis [Internet]. 2011;70(7):1243–50. Available at: https://www.sciencedirect.com/science/article/pii/S0003496724100489 31. Nerurkar L, Siebert S, McInnes IB, Cavanagh J. Rheumatoid arthritis and depression: an inflammatory perspective. The lancet Psychiatry. Februarie 2019;6(2):164–73. 32. Sturgeon JA, Finan PH, Zautra AJ. Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways. Nat Rev Rheumatol. September 2016;12(9):532–42. 33. Maldonado G, Ríos C, Paredes C, Ferro C, Intriago MJ, Aguirre C, et al. Depresión en artritis reumatóide . Vol 24, Revista Colombiana de Reumatología . scieloco ; 2017. bl 84–91. 34. Mella LFB, Bértolo MB, Dalgalarrondo P. Depressive symptoms in rheumatoid arthritis. Rev Bras Psiquiatr. September 2010;32(3):257–63. 35. Senra H, Rogers H, Leibach G, Altamar MLP, Plaza SLO, Perrin P, et al. Health-related quality of life and depression in a sample of Latin American adults with rheumatoid arthritis. Int J Rheum Dis. November 2017;20(11):1684–93. 36. Alarcón GS. Epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. Augustus 1995;21(3):589–604. 37. Gotelli E, Campitiello R, Hysa E, Soldano S, Casabella A, Pizzorni C, et al. The epigenetic effects of glucocorticoids, sex hormones and vitamin D as steroidal hormones in rheumatic musculoskeletal diseases. Clin Exp Rheumatol. November 2024;42(11):2131–40. 38. Molina E, Del Rincon I, Restrepo JF, Battafarano DF, Escalante A. Association of socioeconomic status with treatment delays, disease activity, joint damage, and disability in rheumatoid arthritis. Arthritis Care Res (Hoboken). Julie 2015;67(7):940–6. 39. Sullivan PW, Ghushchyan V, Huang X-Y, Globe DR. Influence of rheumatoid arthritis on employment, function, and productivity in a nationally representative sample in the United States. J Rheumatol. Maart 2010;37(3):544–9. 40. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. Januarie 1995;38(1):19–28. 41. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. September 2001;16(9):606–13. 42. Heidari P, Cross W, Crawford K. Do out-of-pocket costs affect medication adherence in adults with rheumatoid arthritis? A systematic review. Semin Arthritis Rheum. Augustus 2018;48(1):12–21. 43. Kessler RC. Epidemiology of women and depression. J Affect Disord. Maart 2003;74(1):5–13. 44. Wiesenfeld-Hallin Z. Sex differences in pain perception. Gend Med [Internet]. 2005;2(3):137–45. Available at: https://www.sciencedirect.com/science/article/pii/S1550857905800427 45. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. Januarie 2008;9(1):46–56. 46. Prothero L, Barley E, Galloway J, Georgopoulou S, Sturt J. The evidence base for psychological interventions for rheumatoid arthritis: A systematic review of reviews. Int J Nurs Stud. Junie 2018;82:20–9. 47. Jurado-Priego LN, Cueto-Ureña C, Ramírez-Expósito MJ, Martínez-Martos JM. Fibromyalgia: A Review of the Pathophysiological Mechanisms and Multidisciplinary Treatment Strategies. Biomedicines. Julie 2024;12(7). 48. Mian AN, Chaabo K, Wajed J, Subesinghe S, Gullick NJ, Kirkham B, et al. Rheumatoid arthritis patients with fibromyalgic clinical features have significantly less synovitis as defined by power Doppler ultrasound. BMC Musculoskelet Disord. September 2016;17(1):404. 49. Gaujoux-Viala C, Mouterde G, Baillet A, Claudepierre P, Fautrel B, Le Loët X, et al. Evaluating disease activity in rheumatoid arthritis: Which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI. Jt Bone Spine [Internet]. 2012;79(2):149–55. Available at: https://www.sciencedirect.com/science/article/pii/S1297319X11001072 50. Rathbun AM, England BR, Mikuls TR, Ryan AS, Barton JL, Shardell MD, et al. Relationship Between Depression and Disease Activity in United States Veterans With Early Rheumatoid Arthritis Receiving Methotrexate. J Rheumatol. Junie 2021;48(6):813–20. 51. Pincus T, Sokka T. Quantitative measures for assessing rheumatoid arthritis in clinical trials and clinical care. Best Pract Res Clin Rheumatol [Internet]. 2003;17(5):753–81. Available at: https://www.sciencedirect.com/science/article/pii/S1521694203000779 52. Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. Junie 2010;69(6):964–75. 53. Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis. Julie 2006;65(7):845–51. 54. Smolen JS, Aletaha D. The assessment of disease activity in rheumatoid arthritis. Clin Exp Rheumatol. 2010;28(3 Suppl 59):S18-27. 55. Salt E, Frazier SK. Adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a narrative review of the literature. Orthop Nurs. 2010;29(4):260–75. 56. Guler MA, Celik OF, Ayhan FF. The important role of central sensitization in chronic musculoskeletal pain seen in different rheumatic diseases. Clin Rheumatol. Januarie 2020;39(1):269–74. 57. Dey M, Busby A, Elwell H, Lempp H, Pratt A, Young A, et al. Association between social deprivation and disease activity in rheumatoid arthritis: a systematic literature review. RMD open. April 2022;8(1). 58. Sinnathurai P, Buchbinder R, Hill C, Lassere M, March L. Comorbidity in psoriatic arthritis and rheumatoid arthritis. Intern Med J. November 2018;48(11):1360–8. 59. Smolen JS, Landewé RBM, Bergstra SA, Kerschbaumer A, Sepriano A, Aletaha D, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. Januarie 2023;82(1):3–18. 60. Pineda C, Caballero-Uribe C V. Challenges and opportunities for diagnosis and treatment of rheumatoid arthritis in Latin America. Vol 34 Suppl 1, Clinical rheumatology. Germany; 2015. bl S5-7. |
| dc.rights.en.fl_str_mv |
Attribution-NonCommercial-ShareAlike 4.0 International |
| dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| dc.rights.uri.none.fl_str_mv |
http://creativecommons.org/licenses/by-nc-sa/4.0/ |
| dc.rights.local.spa.fl_str_mv |
Acceso abierto |
| dc.rights.accessrights.none.fl_str_mv |
https://purl.org/coar/access_right/c_abf2 |
| rights_invalid_str_mv |
Attribution-NonCommercial-ShareAlike 4.0 International http://creativecommons.org/licenses/by-nc-sa/4.0/ Acceso abierto https://purl.org/coar/access_right/c_abf2 http://purl.org/coar/access_right/c_abf2 |
| dc.format.mimetype.none.fl_str_mv |
application/pdf |
| dc.publisher.program.spa.fl_str_mv |
Especialización en Medicina Interna |
| dc.publisher.grantor.spa.fl_str_mv |
Universidad El Bosque |
| dc.publisher.faculty.spa.fl_str_mv |
Facultad de Medicina |
| institution |
Universidad El Bosque |
| bitstream.url.fl_str_mv |
https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/9947f3da-f09e-4e29-9b76-64c8ba7e83f6/download https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/ebd28388-e5b7-4635-abd3-f88812893ed9/download https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/51e6831d-3ff2-4d99-a1b4-2c528dcdab56/download https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/cba03c2c-df70-4bc1-a0ce-697409799e73/download https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/da271fca-1901-49c0-b507-80623d799a3d/download https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/100b909e-5d15-4052-a6fc-3caa598aec30/download https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/3776d8aa-d18f-4d5c-a9c4-2afa10d5ba0f/download |
| bitstream.checksum.fl_str_mv |
c4309eaa226e0b21e066f15dc3a60cd5 17cc15b951e7cc6b3728a574117320f9 3de64dafd097652b7eb20d4fe657a1db e34695f4337321527f009a4f340331ec 5643bfd9bcf29d560eeec56d584edaa9 b6d2e3a782213222d14e81fedebc9f27 36bf06b6917060f2a9e227917889c5a0 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio Institucional Universidad El Bosque |
| repository.mail.fl_str_mv |
bibliotecas@biteca.com |
| _version_ |
1849967124933509120 |
| spelling |
Quintana López, GerardoRodríguez Velandia, Yhojan AlexisRodríguez Yhojan [0000-0002-0956-1491]2025-07-29T14:20:11Z2025-07-29T14:20:11Z2025-07https://hdl.handle.net/20.500.12495/15545instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquerepourl:https://repositorio.unbosque.edu.coEn varios estudios se ha identificado una conexión significativa entre la artritis reumatoide (AR) y la depresión, dado el alto índice de depresión registrado entre los pacientes con AR. La evidencia creciente sugiere que la AR puede ser un factor de riesgo para el desarrollo de depresión, y los pacientes que presentan ambas condiciones tienden a tener resultados clínicos menos favorables. No obstante, en Colombia, no se dispone de estimaciones precisas sobre la prevalencia de depresión en individuos con AR, y los estudios existentes enfrentan diversas limitaciones metodológicas. Este estudio se propone investigar la magnitud del problema de la depresión en pacientes con AR mediante la estimación de su prevalencia en una cohorte colombiana. Además, analizará cómo los síntomas depresivos influyen en la actividad de la enfermedad, al tiempo que identificará los factores que afectan la relación entre ambas enfermedades a lo largo del tiempo.Fundación Santa Fe de BogotáEspecialista en Medicina InternaEspecializaciónIn multiple studies, a significant connection has been identified between rheumatoid arthritis (RA) and depression, given the high rate of depression recorded among RA patients. Growing evidence suggests that RA may be a risk factor for developing depression, and patients with both conditions tend to have less favourable clinical outcomes. However, in Colombia, precise estimates of the prevalence of depression in individuals with RA are not available, and existing studies face various methodological limitations. This study aims to investigate the magnitude of the depression problem in RA patients by estimating its prevalence in a Colombian cohort. Additionally, it will analyse how depressive symptoms influence disease activity while identifying factors affecting the relationship between these two diseases over time.application/pdfAttribution-NonCommercial-ShareAlike 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-sa/4.0/Acceso abiertohttps://purl.org/coar/access_right/c_abf2http://purl.org/coar/access_right/c_abf2Artritis reumatoideDepresiónActividad de la enfermedadRheumatoid arthritisDepressionDisease activityWB 115Actividad de la enfermedad y depresión en una cohorte colombiana con artritis reumatoideDisease activity and depression in a colombian cohort with rheumatoid arthritisEspecialización en Medicina InternaUniversidad El BosqueFacultad de MedicinaTesis/Trabajo de grado - Monografía - Especializaciónhttps://purl.org/coar/resource_type/c_7a1fhttp://purl.org/coar/resource_type/c_7a1finfo:eu-repo/semantics/bachelorThesishttps://purl.org/coar/version/c_ab4af688f83e57aa1. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet (London, England). Oktober 2016;388(10055):2023–38.2. Ionescu C-E, Popescu CC, Agache M, Dinache G, Codreanu C. Depression in Rheumatoid Arthritis: Prevalence and Effects on Disease Activity. J Clin Med. April 2024;13(7).3. ElSherbiny DA, ElSayed Saad W. Depression in rheumatoid arthritis patients: Screening for a frequent yet underestimated comorbidity. Egypt Rheumatol [Internet]. 2020;42(2):89–93. Available at: https://www.sciencedirect.com/science/article/pii/S11101164193008824. Strand V, Boklage SH, Kimura T, Joly F, Boyapati A, Msihid J. High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab. Arthritis Res Ther. Oktober 2020;22(1):250.5. Maldonado G, Ríos C, Paredes C, Ferro C, Intriago MJ, Aguirre C, et al. Depression in Rheumatoid Arthritis. Rev Colomb Reumatol (English Ed [Internet]. 2017;24(2):84–91. Available at: https://www.elsevier.es/es6. Cui L, Li S, Wang S, Wu X, Liu Y, Yu W, et al. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther. Februarie 2024;9(1):30.7. Fernández-Ávila DG, Rincón-Riaño DN, Bernal-Macías S, Gutiérrez Dávila JM, Rosselli D. Prevalencia de la artritis reumatoide en Colombia según información del Sistema Integral de Información de la Protección Social . Vol 26, Revista Colombiana de Reumatología . scieloco ; 2019. bl 83–7.8. Anderson JK, Zimmerman L, Caplan L, Michaud K. Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score with 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), C. Arthritis Care Res (Hoboken). November 2011;63 Suppl 1:S14-36.9. Toro-Gutiérrez CE, Arbeláez-Cortés Á, Fernández-Aldana AR, Mejía-Romero RA, Méndez Patarroyo P, Quintana L. G, et al. Guía de práctica clínica para la detección temprana, el diagnóstico, el tratamiento y el seguimiento de los pacientes con artritis reumatoide. Asociación Colombiana de Reumatología, 2022. Rev Colomb Reumatol [Internet]. 2017;24(2):205–22. Available at: https://www.elsevier.es/es10. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England). November 2018;392(10159):1789–858.11. Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G, et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. Julie 2011;9:9012. Social FES. Estudio Nacional de Salud Mental Colombia 2003. 2003.13. Malhi GS, Mann JJ. Depression. Lancet (London, England). November 2018;392(10161):2299–312.14. Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, et al. Major depressive disorder. Nat Rev Dis Prim. September 2016;2:16065.15. Arlington: American Psychiatric Publishing. Diagnostic and statistical manual of mental disorders. 2013;16. Diez-Quevedo C, Rangil T, Sanchez-Planell L, Kroenke K, Spitzer RL. Validation and utility of the patient health questionnaire in diagnosing mental disorders in 1003 general hospital Spanish inpatients. Psychosom Med. 2001;63(4):679–86.17. Castro-Camacho L, Escobar JM, Sáenz-Moncaleano C, Delgado-Barrera L, Aparicio-Turbay S, Molano JC, et al. [Mental Health in the General Hospital: Results of the Patient Health Questionnaire (PHQ) in Four Hospital Services]. Rev Colomb Psiquiatr. Maart 2012;41(1):61–85.18. Tejada PA, Jaramillo LE, Sánchez-Pedraza R. Revisión crítica sobre los instrumentos para la evaluación psiquiátrica en atención primaria . Vol 62, Revista de la Facultad de Medicina . scieloco ; 2014. bl 101–10.19. Maurer DM, Raymond TJ, Davis BN. Depression: Screening and Diagnosis. Am Fam Physician. Oktober 2018;98(8):508–15.20. Englbrecht M, Alten R, Aringer M, Baerwald CG, Burkhardt H, Eby N, et al. Validation of Standardized Questionnaires Evaluating Symptoms of Depression in Rheumatoid Arthritis Patients: Approaches to Screening for a Frequent Yet Underrated Challenge. Arthritis Care Res (Hoboken). Januarie 2017;69(1):58–66.21. Hitchon CA, Zhang L, Peschken CA, Lix LM, Graff LA, Fisk JD, et al. Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). Augustus 2020;72(8):1130–9.22. Smarr KL, Keefer AL. Measures of Depression and Depressive Symptoms. Arthritis Care Res (Hoboken). Oktober 2020;72 Suppl 1:608–29.23. Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). Desember 2013;52(12):2136–48.24. Levis B, Benedetti A, Thombs BD. Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. April 2019;365:l1476.25. Manne SL, Zautra AJ. Coping with arthritis. Current status and critique. Arthritis Rheum. November 1992;35(11):1273–80.26. Kato T. Frequently Used Coping Scales: A Meta-Analysis. Stress Heal J Int Soc Investig Stress. Oktober 2015;31(4):315–23.27. Rodríguez-Franco L, Cano-García F, Picabia Y. Evaluación de las estrategias de afrontamiento del dolor crónico. Actas Esp Psiquiatr. 01 Januarie 2004;32.28. Guarino L, Sojo V, Bethelmy L. Adaptación y Validación Preliminar de la Versión Hispana del Cuestionario de Estilos de Afrontamiento (Coping Style Questionnaire, CSQ). Psicol Conductual. 01 Januarie 2007;15:173.29. Delgado M, Cano-Vindel A, Pérez Nieto M. Afrontamiento y artritis reumatoide: una revisión crítica. Ansiedad y Estres. 01 Oktober 2001;7:139–50.30. Vriezekolk JE, van Lankveld WGJM, Geenen R, van den Ende CHM. Longitudinal association between coping and psychological distress in rheumatoid arthritis: a systematic review. Ann Rheum Dis [Internet]. 2011;70(7):1243–50. Available at: https://www.sciencedirect.com/science/article/pii/S000349672410048931. Nerurkar L, Siebert S, McInnes IB, Cavanagh J. Rheumatoid arthritis and depression: an inflammatory perspective. The lancet Psychiatry. Februarie 2019;6(2):164–73.32. Sturgeon JA, Finan PH, Zautra AJ. Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways. Nat Rev Rheumatol. September 2016;12(9):532–42.33. Maldonado G, Ríos C, Paredes C, Ferro C, Intriago MJ, Aguirre C, et al. Depresión en artritis reumatóide . Vol 24, Revista Colombiana de Reumatología . scieloco ; 2017. bl 84–91.34. Mella LFB, Bértolo MB, Dalgalarrondo P. Depressive symptoms in rheumatoid arthritis. Rev Bras Psiquiatr. September 2010;32(3):257–63.35. Senra H, Rogers H, Leibach G, Altamar MLP, Plaza SLO, Perrin P, et al. Health-related quality of life and depression in a sample of Latin American adults with rheumatoid arthritis. Int J Rheum Dis. November 2017;20(11):1684–93.36. Alarcón GS. Epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. Augustus 1995;21(3):589–604.37. Gotelli E, Campitiello R, Hysa E, Soldano S, Casabella A, Pizzorni C, et al. The epigenetic effects of glucocorticoids, sex hormones and vitamin D as steroidal hormones in rheumatic musculoskeletal diseases. Clin Exp Rheumatol. November 2024;42(11):2131–40.38. Molina E, Del Rincon I, Restrepo JF, Battafarano DF, Escalante A. Association of socioeconomic status with treatment delays, disease activity, joint damage, and disability in rheumatoid arthritis. Arthritis Care Res (Hoboken). Julie 2015;67(7):940–6.39. Sullivan PW, Ghushchyan V, Huang X-Y, Globe DR. Influence of rheumatoid arthritis on employment, function, and productivity in a nationally representative sample in the United States. J Rheumatol. Maart 2010;37(3):544–9.40. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. Januarie 1995;38(1):19–28.41. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. September 2001;16(9):606–13.42. Heidari P, Cross W, Crawford K. Do out-of-pocket costs affect medication adherence in adults with rheumatoid arthritis? A systematic review. Semin Arthritis Rheum. Augustus 2018;48(1):12–21.43. Kessler RC. Epidemiology of women and depression. J Affect Disord. Maart 2003;74(1):5–13.44. Wiesenfeld-Hallin Z. Sex differences in pain perception. Gend Med [Internet]. 2005;2(3):137–45. Available at: https://www.sciencedirect.com/science/article/pii/S155085790580042745. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. Januarie 2008;9(1):46–56.46. Prothero L, Barley E, Galloway J, Georgopoulou S, Sturt J. The evidence base for psychological interventions for rheumatoid arthritis: A systematic review of reviews. Int J Nurs Stud. Junie 2018;82:20–9.47. Jurado-Priego LN, Cueto-Ureña C, Ramírez-Expósito MJ, Martínez-Martos JM. Fibromyalgia: A Review of the Pathophysiological Mechanisms and Multidisciplinary Treatment Strategies. Biomedicines. Julie 2024;12(7).48. Mian AN, Chaabo K, Wajed J, Subesinghe S, Gullick NJ, Kirkham B, et al. Rheumatoid arthritis patients with fibromyalgic clinical features have significantly less synovitis as defined by power Doppler ultrasound. BMC Musculoskelet Disord. September 2016;17(1):404.49. Gaujoux-Viala C, Mouterde G, Baillet A, Claudepierre P, Fautrel B, Le Loët X, et al. Evaluating disease activity in rheumatoid arthritis: Which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI. Jt Bone Spine [Internet]. 2012;79(2):149–55. Available at: https://www.sciencedirect.com/science/article/pii/S1297319X1100107250. Rathbun AM, England BR, Mikuls TR, Ryan AS, Barton JL, Shardell MD, et al. Relationship Between Depression and Disease Activity in United States Veterans With Early Rheumatoid Arthritis Receiving Methotrexate. J Rheumatol. Junie 2021;48(6):813–20.51. Pincus T, Sokka T. Quantitative measures for assessing rheumatoid arthritis in clinical trials and clinical care. Best Pract Res Clin Rheumatol [Internet]. 2003;17(5):753–81. Available at: https://www.sciencedirect.com/science/article/pii/S152169420300077952. Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. Junie 2010;69(6):964–75.53. Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis. Julie 2006;65(7):845–51.54. Smolen JS, Aletaha D. The assessment of disease activity in rheumatoid arthritis. Clin Exp Rheumatol. 2010;28(3 Suppl 59):S18-27.55. Salt E, Frazier SK. Adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a narrative review of the literature. Orthop Nurs. 2010;29(4):260–75.56. Guler MA, Celik OF, Ayhan FF. The important role of central sensitization in chronic musculoskeletal pain seen in different rheumatic diseases. Clin Rheumatol. Januarie 2020;39(1):269–74.57. Dey M, Busby A, Elwell H, Lempp H, Pratt A, Young A, et al. Association between social deprivation and disease activity in rheumatoid arthritis: a systematic literature review. RMD open. April 2022;8(1).58. Sinnathurai P, Buchbinder R, Hill C, Lassere M, March L. Comorbidity in psoriatic arthritis and rheumatoid arthritis. Intern Med J. November 2018;48(11):1360–8.59. Smolen JS, Landewé RBM, Bergstra SA, Kerschbaumer A, Sepriano A, Aletaha D, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. Januarie 2023;82(1):3–18.60. Pineda C, Caballero-Uribe C V. Challenges and opportunities for diagnosis and treatment of rheumatoid arthritis in Latin America. Vol 34 Suppl 1, Clinical rheumatology. Germany; 2015. bl S5-7.spaORIGINALTrabajo de grado.pdfTrabajo de grado.pdfapplication/pdf1102681https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/9947f3da-f09e-4e29-9b76-64c8ba7e83f6/downloadc4309eaa226e0b21e066f15dc3a60cd5MD56trueAnonymousREAD2026-07-28LICENSElicense.txtlicense.txttext/plain; charset=utf-82000https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/ebd28388-e5b7-4635-abd3-f88812893ed9/download17cc15b951e7cc6b3728a574117320f9MD55falseAnonymousREADCarta de autorizacion.pdfapplication/pdf145811https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/51e6831d-3ff2-4d99-a1b4-2c528dcdab56/download3de64dafd097652b7eb20d4fe657a1dbMD58falseBiblioteca - (Publicadores)READAnexo 1 acta de aprobacion.pdfapplication/pdf560674https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/cba03c2c-df70-4bc1-a0ce-697409799e73/downloade34695f4337321527f009a4f340331ecMD59falseBiblioteca - (Publicadores)READCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-81160https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/da271fca-1901-49c0-b507-80623d799a3d/download5643bfd9bcf29d560eeec56d584edaa9MD57falseAnonymousREADTEXTTrabajo de grado.pdf.txtTrabajo de grado.pdf.txtExtracted texttext/plain93314https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/100b909e-5d15-4052-a6fc-3caa598aec30/downloadb6d2e3a782213222d14e81fedebc9f27MD510falseAnonymousREAD2026-07-28THUMBNAILTrabajo de grado.pdf.jpgTrabajo de grado.pdf.jpgGenerated Thumbnailimage/jpeg2582https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/3776d8aa-d18f-4d5c-a9c4-2afa10d5ba0f/download36bf06b6917060f2a9e227917889c5a0MD511falseAnonymousREAD2026-07-2820.500.12495/15545oai:pruebas-update-repositorio-unbosque.cloudbiteca.com:20.500.12495/155452025-07-30T10:01:17.540Zhttp://creativecommons.org/licenses/by-nc-sa/4.0/Attribution-NonCommercial-ShareAlike 4.0 Internationalembargo2026-07-28https://pruebas-update-repositorio-unbosque.cloudbiteca.comRepositorio Institucional Universidad El Bosquebibliotecas@biteca.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 |
